128 related articles for article (PubMed ID: 7632775)
1. Tissue blood flow estimation with copper(II)-pyruvaldehyde bis (N-4-methylthiosemicarbazone) and PET.
Young H; Carnochan P; Zweit J; Babich J; Cherry S; Ott R
J Nucl Biol Med (1991); 1994 Dec; 38(4 Suppl 1):89-91. PubMed ID: 7632775
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of copper(II)-pyruvaldehyde bis (N-4-methylthiosemicarbazone) for tissue blood flow measurement using a trapped tracer model.
Young H; Carnochan P; Zweit J; Babich J; Cherry S; Ott R
Eur J Nucl Med; 1994 Apr; 21(4):336-41. PubMed ID: 8005157
[TBL] [Abstract][Full Text] [Related]
3. Human biodistribution and dosimetry of the PET perfusion agent copper-62-PTSM.
Wallhaus TR; Lacy J; Whang J; Green MA; Nickles RJ; Stone CK
J Nucl Med; 1998 Nov; 39(11):1958-64. PubMed ID: 9829589
[TBL] [Abstract][Full Text] [Related]
4. Measurement of regional cerebral blood flow with copper-62-PTSM and a three-compartment model.
Okazawa H; Yonekura Y; Fujibayashi Y; Mukai T; Nishizawa S; Magata Y; Ishizu K; Tamaki N; Konishi J
J Nucl Med; 1996 Jul; 37(7):1089-93. PubMed ID: 8965175
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a potential generator-produced PET tracer for cerebral perfusion imaging: single-pass cerebral extraction measurements and imaging with radiolabeled Cu-PTSM.
Mathias CJ; Welch MJ; Raichle ME; Mintun MA; Lich LL; McGuire AH; Zinn KR; John EK; Green MA
J Nucl Med; 1990 Mar; 31(3):351-9. PubMed ID: 2308007
[TBL] [Abstract][Full Text] [Related]
6. Clinical application and quantitative evaluation of generator-produced copper-62-PTSM as a brain perfusion tracer for PET.
Okazawa H; Yonekura Y; Fujibayashi Y; Nishizawa S; Magata Y; Ishizu K; Tanaka F; Tsuchida T; Tamaki N; Konishi J
J Nucl Med; 1994 Dec; 35(12):1910-5. PubMed ID: 7989968
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive 64Cu-ATSM and PET/CT assessment of hypoxia in rat skeletal muscles and tendons during muscle contractions.
Skovgaard D; Kjaer M; Madsen J; Kjaer A
J Nucl Med; 2009 Jun; 50(6):950-8. PubMed ID: 19443591
[TBL] [Abstract][Full Text] [Related]
8. Tissue perfusion of copper-62-PTSM: relevance of studies in animal models as predictors of clinical radiopharmaceutical performance.
Fritzberg AR
J Nucl Med; 1995 Aug; 36(8):1456-7. PubMed ID: 7629594
[No Abstract] [Full Text] [Related]
9. Copper(II) bis(thiosemicarbazone) complexes as potential tracers for evaluation of cerebral and myocardial blood flow with PET.
Green MA; Klippenstein DL; Tennison JR
J Nucl Med; 1988 Sep; 29(9):1549-57. PubMed ID: 3261785
[TBL] [Abstract][Full Text] [Related]
10. Assessment of regional myocardial and renal blood flow with copper-PTSM and positron emission tomography.
Shelton ME; Green MA; Mathias CJ; Welch MJ; Bergmann SR
Circulation; 1990 Sep; 82(3):990-7. PubMed ID: 2394015
[TBL] [Abstract][Full Text] [Related]
11. Radiolabeling rhesus monkey CD34+ hematopoietic and mesenchymal stem cells with 64Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) for microPET imaging.
Huang J; Lee CC; Sutcliffe JL; Cherry SR; Tarantal AF
Mol Imaging; 2008; 7(1):1-11. PubMed ID: 18384718
[TBL] [Abstract][Full Text] [Related]
12. Generator-produced copper-62-PTSM as a myocardial PET perfusion tracer compared with nitrogen-13-ammonia.
Tadamura E; Tamaki N; Okazawa H; Fujibayashi Y; Kudoh T; Yonekura Y; Magata Y; Nohara R; Sasayama S; Konishi J
J Nucl Med; 1996 May; 37(5):729-35. PubMed ID: 8965135
[TBL] [Abstract][Full Text] [Related]
13. Quantification of regional myocardial perfusion with generator-produced 62Cu-PTSM and positron emission tomography.
Herrero P; Markham J; Weinheimer CJ; Anderson CJ; Welch MJ; Green MA; Bergmann SR
Circulation; 1993 Jan; 87(1):173-83. PubMed ID: 8419005
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of copper-PTSM in isolated hearts: a novel tracer for measuring blood flow with positron emission tomography.
Shelton ME; Green MA; Mathias CJ; Welch MJ; Bergmann SR
J Nucl Med; 1989 Nov; 30(11):1843-7. PubMed ID: 2809749
[TBL] [Abstract][Full Text] [Related]
15. A potential copper radiopharmaceutical for imaging the heart and brain: copper-labeled pyruvaldehyde bis(N4-methylthiosemicarbazone).
Green MA
Int J Rad Appl Instrum B; 1987; 14(1):59-61. PubMed ID: 3583756
[TBL] [Abstract][Full Text] [Related]
16. Regional myocardial perfusion assessed with generator-produced copper-62-PTSM and PET.
Herrero P; Hartman JJ; Green MA; Anderson CJ; Welch MJ; Markham J; Bergmann SR
J Nucl Med; 1996 Aug; 37(8):1294-300. PubMed ID: 8708759
[TBL] [Abstract][Full Text] [Related]
17. Production and tumour uptake of [64Cu]Pyruvaldehyde-bis (N4-methylthiosemicarbazone) for PET and/or therapeutic purposes.
Jalilian AR; Rowshanfarzad P; Kamrani YY; Shafaii K; Mirzaii M
Nucl Med Rev Cent East Eur; 2007; 10(1):6-11. PubMed ID: 17694494
[TBL] [Abstract][Full Text] [Related]
18. Mixed bis(thiosemicarbazone) ligands for the preparation of copper radiopharmaceuticals: synthesis and evaluation of tetradentate ligands containing two dissimilar thiosemicarbazone functions.
Lim JK; Mathias CJ; Green MA
J Med Chem; 1997 Jan; 40(1):132-6. PubMed ID: 9016338
[TBL] [Abstract][Full Text] [Related]
19. Species-dependent binding of copper(II) bis(thiosemicarbazone) radiopharmaceuticals to serum albumin.
Mathias CJ; Bergmann SR; Green MA
J Nucl Med; 1995 Aug; 36(8):1451-5. PubMed ID: 7629593
[TBL] [Abstract][Full Text] [Related]
20. Investigation of copper-PTSM as a PET tracer for tumor blood flow.
Mathias CJ; Welch MJ; Perry DJ; McGuire AH; Zhu X; Connett JM; Green MA
Int J Rad Appl Instrum B; 1991; 18(7):807-11. PubMed ID: 1787092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]